Green tea may reduce lung cancer risk in smokers

Green tea could modify the effect of cigarette smoking on lung cancer risk – Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan_11-14, 2010.

Rate of increase for obesity in US slowing

Prevalence of Obesity Among U.S. Adults Still High, But Recent Data Suggest Rates May Have Stabilized – The prevalence of adults in the U.S. who are obese is still high, with about one-third of adults obese in 2007-2008, although new data suggest that the rate of increase for obesity in the U.S. in recent decades may be slowing.

Yoga reduces inflammation, stress, aging

Yoga reduces cytokine levels known to promote inflammation – Regularly practicing yoga exercises may lower a number of compounds in the blood and reduce the level of inflammation that normally rises because of both normal aging and stress, a new study has shown.

Natural vitamin E protects brain after stroke

Study reveals how one form of natural vitamin E protects brain after stroke – Blocking the function of an enzyme in the brain with a specific kind of vitamin E can prevent nerve cells from dying after a stroke, new research suggests.

Exercise may prevent, improve cognitive impairment

Aerobic exercise has a better effect on cognition and other biomarkers associated with Alzheimer disease pathology for older adults with mild cognitive impairment. – Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition.

Physicians’ moods affect quality of care

Physicians’ moods affect quality of care, according to Ben-Gurion University study – A new study by a researcher at Ben-Gurion University of the Negev (BGU) reveals that physicians’ moods impact the number of prescriptions, referrals and lab tests ordered, as well as the amount of time they spend talking with their patients.

Weekend strokes may receive more aggressive treatment

Patients experiencing acute ischemic stroke (AIS) are more likely to receive tissue plasminogen activator on weekends than on weekdays. – Stroke patients admitted to the hospital on the weekend appear more likely to receive the clot-dissolving medication tissue plasminogen activator than patients admitted during the week. However, stroke death rates appear similar among weekend and weekday admissions.

Hospital superbug MRSA diffused by patients

Clustering MRSA in Europe indicates diffusion through regional health-care networks – A new study finds that methicillin-resistant Staphylococcus aureus (MRSA) ?responsible for several difficult-to-treat infections including blood poisoning and pneumonia and a particular problem in hospitals ? occurs in distinct geographical clusters across Europe, indicating that MRSA is being diffused by patients moving between hospitals rather than spreading freely in the community.

Two new genes identified causing ankylosing spondylitis

UT rheumatologists advance genetic research related to disabling form of arthritis – Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease.

Gene linked to aggressive form of prostate cancer

Genetic variant associated with aggressive form of prostate cancer – Researchers at Wake Forest University Baptist Medical Center and colleagues have identified the first genetic variant associated with aggressive prostate cancer, proving the concept that genetic information may one day be used in combination with other factors to guide treatment decisions.

Testing gene therapy for Alzheimer’s disease

University Hospitals Case Medical Center testing gene therapy for Alzheimer’s disease — Phase 2 study will examine effectiveness, safety of nerve growth factor in slowing AD – University Hospitals Case Medical Center is one of 12 sites conducting the first Phase 2 clinical trial of a gene therapy for Alzheimer’s disease (AD). The study uses a viral-based gene transfer system called CERE-110, which is designed to deliver nerve growth factor (NGF) into the brain.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia